[1]
Robinson, S. 2024. Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure. Canadian Hematology Today. 3, 2 (Jun. 2024), 49–53. DOI:https://doi.org/10.58931/cht.2024.3255.